BONESUPPORT: Initial take on Q1 2023 results - Redeye

Redeye provides an initial take on BONESUPPORT’s Q1 results and we note another estimate beat on sales, resulting in a break-even operating result. Furthermore, CERAMENT G in the US came in significantly higher than our (conservative) numbers. We anticipate a positive share price reaction of c10%. We will return shortly with a more in-depth take on the report following the conference call.

Länk till analysen i sin helhet: https://www.redeye.se/research/898431/bonesupport-initial-take-on-q1-2023-results?utm_source=finwire&utm_medium=RSS